Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-003 · Medication safety
MED-MET-002: Metformin initiation/continuation review zone
Metformin initiation/continuation review zone. Evaluates medication active or proposed is metformin.
Condition
- All of:
- medication active or proposed == metformin
- eGFR selected >= 30
- eGFR selected < 45
What it reports
- Medication flag: metformin renal review zone
- Message: Do not initiate in the eGFR 30-45 range per labeling; if already taking, assess benefit-risk of continuing. Verify current product labeling.
Evidence
- R8GLUCOPHAGE / GLUCOPHAGE XR Prescribing Information - Renal Impairment Recommendations. U.S. Food and Drug Administration (FDA) - Drugs@FDA labeling, 2017.Supports: metformin medication safety thresholds
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.